For example, targeting cell surface expression of HSPA5 on acute myeloid leukemia (AML) blasts with CAR-T cells has shown promising anti-leukemic activity without affecting hematopoietic progenitor cells, indicating a potential therapeutic window. The gene discussed is HSPA5; the disease is acute myeloid leukemia.